Increased risk of breast cancer has been associated with diabetes in numerous epidemiological studies [27], therefore we also studied the effect of insulin analogues on the production of PIP3 in breast cancer derived cell lines using a new, highly sensitive BRET-based assay. This evidence concerns the gene INS and breast cancer.